Healthcare -
Biotechnology - NASDAQ - US
$ 18.05
2.67 %
$ 1.24 B
Market Cap
-3.77
P/E
ARVN - GROSS PROFIT
Gross Profit ARVN - Arvinas, Inc.
78.5 M
LAST VALUE
38.88%
2 YEAR CAGR
40.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR